Predicting the risk of end-stage renal disease in the population-based setting: A retrospective case-control study

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Johnson, Eric S ^a   Smith, David H ^a   Thorp, Micah L ^b   Yang, Xiuhai ^a   Juhaeri, Juhaeri ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b Sanofi Aventis ^*  (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROTEIN; URIC ACID;

AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; URIC ACID URINE LEVEL; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; FEMALE; HEART FAILURE; MALE; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROTEINURIA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955565173     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-17     Document Type: Article

References (15)

1. Executive Summary of the Kidney Disease Outcomes Quality Initiative. National Kidney Foundation, Am J Kidney Dis 2002 39 17 S31
2. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. TV Perneger PK Whelton MJ Klag, N Engl J Med 1994 331 1675 79 10.1056/NEJM199412223312502 7969358 (Pubitemid 24373619)
3. Acetaminophen, aspirin, and chronic renal failure. CM Fored E Ejerblad P Lindblad,, et al. N Engl J Med 2001 345 1801 08 10.1056/NEJMoa010323 11752356
4. Risk factors for end-stage renal disease: 25-year follow-up. CY Hsu C Iribarren CE McCulloch J Darbinian AS Go, Arch Intern Med 2009 169 342 50 10.1001/archinternmed.2008.605 19237717
5. Haematocrit and the risk of developing end-stage renal disease. K Iseki Y Ikemiya C Iseki S Takishita, Nephrol Dial Transplant 2003 18 899 905 10.1093/ndt/gfg021 12686662 (Pubitemid 36592530)
6. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. HI Feldman LJ Appel GM Chertow,, et al. J Am Soc Nephrol 2003 14 148 S153 10.1097/01.ASN.0000070149.78399.CE 12819321
7. The Study of Treatment for Renal Insufficiency: Data and Evaluation (STRIDE), a national registry of chronic kidney disease. M Rao AT Kausz D Mitchell,, et al. Semin Dial 2002 15 366 9 10.1046/j.1525-139X.2002.00088.x 12358642
8. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. ES Johnson ML Thorp RW Platt,, et al. Am J Kidney Dis 2008 52 653 660 10.1053/j.ajkd.2008.04.026 18585833
9. Kaiser Permanente Medical Care Program. J Selby D Smith ES Johnson,, et al. Pharmacoepidemiology New York: John Wiley & Sons, Strom BL, 4 2005 241 260
10. Case-Control Studies. KJ Rothman S Greenland TL Lash, Modern Epidemiology Philadelphia: Lippincott Williams & Wilkins, Rothman KJ, Greenland S, Lash TL, 3 2008 111 127
11. Problems and potentials in modelling survival. LR Smith FE Harrell LH Muhlbaier, Medical Effectiveness Research Data Methods (Summary Report) Rockville, MD: US Dept of HHS, Grady ML, Schwartz, 1992 151 159
12. FE Harrell, Regression Modelling Strategies New York: Springer 2001
13. A critical look at methods for handling missing covariates in epidemiologic regression analyses. S Greenland WD Finkle, Am J Epidemiol 1995 142 1255 1264 7503045 (Pubitemid 26006424)
14. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. United States Renal Data Systems: Incidence and Prevalence (Chapter 2). In: Atlas of End-Stage Renal Disease (Volume 2), Bethesda, Maryland: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2010 253 66
15. Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions. TV Perneger FL Brancati PK Whelton,, et al. Am J Kidney Dis 1995 25 722 731 10.1016/0272-6386(95)90548-0 7747726